Association of genetic variations with pharmacokinetics and lipid-lowering response to atorvastatin in healthy Korean subjects
Hye In Woo,1 Suk Ran Kim,2 Wooseong Huh,3,4 Jae-Wook Ko,4 Soo-Youn Lee4,5 1Department of Laboratory Medicine, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, Korea; 2Clinical Research and Development, Hanmi Pharm. Co., Ltd., Seoul, Korea; 3Department of Medicine, 4De...
Saved in:
Main Authors: | Woo HI (Author), Kim SR (Author), Huh W (Author), Ko JW (Author), Lee SY (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2017-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A pharmacokinetic and pharmacodynamic drug interaction between rosuvastatin and valsartan in healthy subjects
by: Jung JA, et al.
Published: (2015) -
Co-Administration of Vonoprazan, Not Tegoprazan, Affects the Pharmacokinetics of Atorvastatin in Healthy Male Subjects
by: Sejung Hwang, et al.
Published: (2021) -
No pharmacokinetic interactions between candesartan and amlodipine following multiple oral administrations in healthy subjects
by: Kim JR, et al.
Published: (2018) -
Pharmacokinetics and tolerability of eletriptan hydrobromide in healthy Korean subjects
by: Kim YK, et al.
Published: (2018) -
Population Pharmacokinetic Analysis of Tiropramide in Healthy Korean Subjects
by: Seung-Hyun Jeong, et al.
Published: (2020)